L-Dopa: how it may axacerbate parkinsonian symptoms
- 31 December 1986
- journal article
- editorial
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 7, 15-19
- https://doi.org/10.1016/0165-6147(86)90233-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- ?On-off? phenomenon in Parkinson's disease: Correlation to the concentration of dopa in plasmaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- Pharmacokinetics of LevodopaClinical Neuropharmacology, 1984
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- ON-OFF FLUCTUATIONS IN PARKINSON'S DISEASEBrain, 1984
- Deficits in locomotor behaviour and motor performance after central 6-hydroxydopamine or peripheralL-DOPABrain Research, 1983
- An alternative approach to developing dopamine-receptor agonists with central presynaptic actions following oral administration: A comparison between apomorphine, bromocriptine, and the novel compound RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane)Drug Development Research, 1983
- Early onset of the "on-off" phenomenon in children with symptomatic Parkinsonism.Journal of Neurology, Neurosurgery & Psychiatry, 1982
- The use of L-DOPA in Parkinson's disease: a 20 year follow-upTrends in Pharmacological Sciences, 1981
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Evidence for dopamine receptors mediating sedation in the mouse brainNature, 1976